Ceryvyn Therapeutics Ltd. (CYVNY)
0.0232
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Ceryvyn Therapeutics Max Drawdown (5Y) : 99.95% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.95% |
| June 30, 2026 | 99.95% |
| May 31, 2026 | 99.95% |
| April 30, 2026 | 99.95% |
| March 31, 2026 | 99.95% |
| February 28, 2026 | 99.95% |
| January 31, 2026 | 99.95% |
| December 31, 2025 | 99.91% |
| November 30, 2025 | 99.48% |
| October 31, 2025 | 92.51% |
| September 30, 2025 | 92.51% |
| August 31, 2025 | 92.51% |
| July 31, 2025 | 92.51% |
| June 30, 2025 | 92.51% |
| May 31, 2025 | 92.51% |
| April 30, 2025 | 92.51% |
| March 31, 2025 | 92.51% |
| February 28, 2025 | 92.51% |
| January 31, 2025 | 92.51% |
| December 31, 2024 | 92.51% |
| November 30, 2024 | 92.51% |
| October 31, 2024 | 92.51% |
| September 30, 2024 | 92.51% |
| August 31, 2024 | 92.51% |
| July 31, 2024 | 92.51% |
| Date | Value |
|---|---|
| June 30, 2024 | 92.51% |
| May 31, 2024 | 92.51% |
| April 30, 2024 | 92.51% |
| March 31, 2024 | 92.51% |
| February 29, 2024 | 92.51% |
| January 31, 2024 | 92.51% |
| December 31, 2023 | 92.51% |
| November 30, 2023 | 92.51% |
| October 31, 2023 | 92.51% |
| September 30, 2023 | 92.04% |
| August 31, 2023 | 89.23% |
| July 31, 2023 | 87.03% |
| June 30, 2023 | 87.03% |
| May 31, 2023 | 85.44% |
| April 30, 2023 | 84.46% |
| March 31, 2023 | 82.25% |
| February 28, 2023 | 82.25% |
| January 31, 2023 | 82.25% |
| December 31, 2022 | 82.25% |
| November 30, 2022 | 82.25% |
| October 31, 2022 | 82.25% |
| September 30, 2022 | 82.25% |
| August 31, 2022 | 82.25% |
| July 31, 2022 | 82.25% |
| June 30, 2022 | 82.25% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Immutep Ltd. | 94.08% |
| CSL Ltd. | 69.95% |
| Propanc Biopharma, Inc. | 100.0% |
| Mesoblast Ltd. | 95.66% |
| Actinogen Medical Ltd. | 99.20% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -84.21 |
| Beta (5Y) | 1.483 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 107.9% |
| Historical Sharpe Ratio (5Y) | -0.6539 |
| Historical Sortino (5Y) | -0.9699 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 45.20% |